Penny stocks are incredibly dangerous investments that can burn new and seasoned investors alike. InvestorPlace’s best micro-cap analysts recommend buying penny stocks, or cheap stocks, only with the strictest of warnings. But while pink sheet stocks can be halved in the blink of an eye, they can also double much quicker than large-cap stocks.
Yet, with the high chances shares fall back to 60 cents per share, it's not worth buying in today. If you want to take a gamble with SNDL stock, take your time. Wait for the markets to fully absorb its past and upcoming dilution.
While penny stocks are always incredibly risky ventures, these publicly traded companies offer interesting catalysts to consider.
Genius Brands dipped badly on company announcements that didn’t hit the mark, but could this be a buying opportunity for GNUS stock?
The early launch of Zomedica's Truforma does not guarantee commercial success. Before you bet on ZOM stock, the company needs to prove itself.
SENS stock is banking on an FDA approval for its diabetes sensor. However, you’ll want to analyze the fundamentals before proceeding.
These 7 penny stocks clearly demonstrate some simple things about understanding the supply and demand dynamics that move stocks.
If you're going to own AACG stock, you'd better be prepared for massive price moves - but if your timing is good, the returns could be huge.
Investors in penny stocks know the prices of many have crashed. But these seven stocks may have room to run higher.
Why should you check out CHEK stock? An FDA approval, along with an impressive year-end capital position, provide a solid case for Check-Cap.
With uranium being the most energy-dense commodity, the fundamental narrative for DNN stock is an incredibly positive one.
Because of they trade at under $5 a share, penny stocks are cheap to buy and a move of only a few cents can result in big profits for investors. Penny stocks are increasingly attracting interest from retail investors who frequent Reddit.
Northern Dynasty Minerals got a boost when the U.S. Army Corps of Engineers accepted its appeal request. Now, NAK stock is still in the game.
Penny stocks are notorious for being highly risky. But these seven have a real risk of reaching zero -- even if a few offer huge potential rewards.
Onconova's targeted anti-cancer agents enhance the bull thesis for ONTX stock, but the stock's volatile price action raises a red flag.
Genius Brands has made high-profile announcements in recent weeks that lit a fire under GNUS stock. Will it now go to the next level?
Even the top penny stocks have their dog days. Here's a celebration of this week's weirdest plays: OCT, SPRT, DLPN, ZOM and SNDL.
Penny stocks are never great bets, but LKYSF stock may be an important exception to that rule, given its huge potential in the Shroom Boom.
The future course of ACST stock depends largely on the company's lead drug candidate, CaPre. Any good news could send the shares higher.
Sundial Growers is not drawing much interest from institutional investors. That leaves SNDL stock with little reward for investors' efforts.
TRXC stock has undergone a name change but that doesn’t change the nature of the investment, for better or for worse.